TXNIP and Hypoglycemia: Similarly, liver specific TXNIP deletion (TXNIP-LKO) caused hypoglycemia and ketoacidosis, which is consistent with the finding of poor glucose production and increased β-hydroxybutyrate release from isolated hepatocytes from TXNIP-LKO mice [99].